SCLC shows near-ubiquitous loss of function of the RB1 and TP53 tumor suppressor genes (George et al. 2015), but a better characterization of the genetic drivers of this cancer and the contribution of its potential cells of origin to tumor characteristics are needed for developing more effective therapies. The gene discussed is RB1; the disease is small cell lung carcinoma.